Product Information
M-PAP 160 MG/5 ML LIQUID is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.0241 per ML under NDC 58657052404. Its NADAC has been published 74 times since May 7, 2025.
Strength
160 mg/5mL
Manufacturer
Method Pharmaceuticals LLCNDC
58657052404
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
4/1/2024
Price Statistics
The NADAC for M-PAP 160 MG/5 ML LIQUID has been published 74 times since May 7, 2025, and over the history we have for it it has declined 23.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0241 per ML |
|---|---|
| All-time high | $0.0336 (Jul 16, 2025) |
| All-time low | $0.0241 (Sep 23, 2026) |
| 52-week high | $0.0331 |
| 52-week low | $0.0241 |
| Median price | $0.0297 |
| Average price | $0.0293 |
| Largest weekly change | +10.8% (Jan 21, 2026) |
| Weeks tracked | 74 |
| Tracking since | May 7, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Method Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of M-PAP 160 MG/5 ML LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for M-PAP 160 MG/5 ML LIQUID, manufactured by Method Pharmaceuticals LLC, is $0.0241 per ML (NDC 58657052404), effective Sep 30, 2026.
How has the price of M-PAP 160 MG/5 ML LIQUID changed over time?
Over the history we have for it, the NADAC for M-PAP 160 MG/5 ML LIQUID has declined 23.2%. It has been tracked across 74 weekly CMS publications since May 7, 2025.
What are the highest and lowest recorded NADAC prices for M-PAP 160 MG/5 ML LIQUID?
Since May 7, 2025, the NADAC for M-PAP 160 MG/5 ML LIQUID has ranged from a low of $0.0241 (Sep 23, 2026) to a high of $0.0336 (Jul 16, 2025), with a median of $0.0297 per ML.
Are there cheaper alternatives to M-PAP 160 MG/5 ML LIQUID?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHLD ACETAMINOPHEN 160 MG/5 ML, is $0.0107 per ML — about 56% below M-PAP 160 MG/5 ML LIQUID.
Who manufactures M-PAP 160 MG/5 ML LIQUID?
M-PAP 160 MG/5 ML LIQUID (NDC 58657052404) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.